SCHEMBL14867413

SCHEMBL14867413

O=C1CC(C2CCCCC2)CC(=O)C1C(=O)c1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.53
MAPT P10636 2/20 0.50
ALOX15 P16050 1/20 0.50
HTT P42858 1/20 0.50
HBB P68871 1/20 0.50
KDM4E B2RXH2 1/20 0.39
GAA P10253 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 1/20 0.38
HSD17B10 Q99714 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
SRD5A2 P31213 1/20 0.38
NPC1 O15118 1/20 0.38
EP300 Q09472 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL169913 0.77 MCL1 (0.65) MCL1MAPTALOX15HTTHBB
SCHEMBL18227958 0.76 HTT (0.52) MCL1MAPTALOX15HTTHBB
SCHEMBL22137390 0.76 SRD5A2 (0.54) MCL1POLBALDH1A1SRD5A2
Biphenyl SCHEMBL26606260 0.75 TSHR (0.61) MCL1KDM4ERAB9APOLBALDH1A1
Biphenyl SCHEMBL10897390 0.75 TSHR (0.61) MCL1KDM4ERAB9APOLBALDH1A1
SCHEMBL10500501 0.75 MAPT (0.50) MCL1MAPTALOX15HTTHBB
Biphenyl SCHEMBL3046481 0.73 TSHR (0.58) MCL1KDM4ERAB9APOLBCYP2C9
Biphenyl SCHEMBL27833272 0.72 POLB (0.64) MCL1MAPTKDM4EGAARAB9A
SCHEMBL7208671 0.72 MAPT (0.55) MCL1MAPTALOX15HTTHBB
SCHEMBL33443 0.71 SRD5A2 (0.67) MCL1RAB9APOLBSRD5A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US claimed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-8846747-B2 Compounds and methods for altering lifespan of eukaryotic organisms UNIVERSITY OF ROCHESTER (US) 2014-09-30 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms SOUTHERN RESEARCH INSTITUTE (US) 2013-04-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130096175-A1 Compounds and Methods for Altering Lifespan of Eukaryotic Organisms HDAC5, AADAC, SIRT1 MCL1 1137/4885MAPT 2167/4885ALOX15 161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.